Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Permanently Discontinued

AVAPRO

SANOFI-AVENTIS CANADA INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is AVAPRO discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that AVAPRO 75MG has been permanently discontinued (last updated January 15, 2025). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Can I still get this?Possibly — same-ingredient product records found
StatusPermanently Discontinued
Same-ingredient products on file6 products
Affected strength75MG
Last updated2025-01-15

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

VAN-IRBESARTAN

VANC PHARMACEUTICALS INC

75MG · DIN 02427087

Same strengthSame dosage formSame routeNo current shortage

RIVA-IRBESARTAN

LABORATOIRE RIVA INC.

75MG · DIN 02425319

Same strengthSame dosage formSame routeNo current shortage

NTP-IRBESARTAN

TEVA CANADA LIMITED

75MG · DIN 02368978

Same strengthSame dosage formSame routeNo current shortage

Other Products

AVAPRO

SANOFI-AVENTIS CANADA INC

150MG · DIN 02237924

Different strengthSame dosage formSame routeNo current shortage

IRBESARTAN

ACTAVIS PHARMA COMPANY

300MG · DIN 02433842

Different strengthSame dosage formSame routeNo current shortage

IPG-IRBESARTAN

MARCAN PHARMACEUTICALS INC

300MG · DIN 02435454

Different strengthSame dosage formSame routeNo current shortage

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02237923

Strength

75MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

IRBESARTAN

See all IRBESARTAN products →

Shortage History